AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dare Bioscience, Inc. Director's Dealing 2014

Jun 26, 2014

34825_dirs_2014-06-26_b18bf179-5d96-4dfb-8826-7baef2820daf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-06-24

Reporting Person: FETZER OLIVER (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-24	Stock Option (right to buy)	$5.73	A	290000	Acquired	2024-06-23	Common Stock (290000)	Direct

Footnotes

F1: This option was granted on June 24, 2014. The option vests as to 2.08333% of the underlying shares monthly through and including June 24, 2018.